Zivo Bioscience
(ZIVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55 | 119 | 10 | 346 | 15 |
| Receivables | N/A | N/A | 20 | N/A | N/A |
| TOTAL | $130 | $223 | $179 | $369 | $70 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $130 | $223 | $179 | $369 | $70 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,190 | 6,717 | 7,050 | 6,653 | 8,423 |
| Accrued Expenses | 2,328 | 2,190 | 2,053 | 1,953 | 2,510 |
| TOTAL | $11,100 | $10,094 | $9,327 | $8,708 | $10,973 |
| Non-Current Liabilities | |||||
| Long Term Debt | 122 | 122 | N/A | N/A | N/A |
| Deferred Revenues | 1,385 | 1,033 | N/A | N/A | N/A |
| TOTAL | $122 | $122 | $N/A | $N/A | $N/A |
| Total Liabilities | $11,221 | $10,216 | $9,327 | $8,708 | $10,973 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 853 | 847 | 847 | 838 | 748 |
| Common Shares | 407 | 407 | 404 | 397 | 358 |
| Retained earnings | -97,171 | -93,668 | -92,501 | -89,958 | -85,826 |
| TOTAL | $-11,091 | $-9,993 | $-9,148 | $-8,339 | $-10,903 |
| Total Liabilities And Equity | $130 | $223 | $179 | $369 | $70 |